LOGIN

Research papers

Solving the Chinese puzzle: What determines reimbursement price in China?

  • By Song X, Kodabuckus S, Patel P
  • 23 December 2022
Read More

Regulatory and reimbursement landscape for Cell and Gene Therapies across Europe

  • By Beards S, Song X, Kodabuckus S
  • 23 December 2022
Read More

Suitability of value-based price forecasting in a crowded landscape: A case study in rheumatoid arthritis

  • By Anstee K, Patel P
  • 13 December 2022
Read More

The relationship between value and price in the free-pricing period and post-assessment price in Germany, a case study in rheumatoid arthritis

  • By Cigerli S, Anstee K, Patel P
  • 3 December 2022
Read More

The National Pricing and Reimbursement Process in China: A 2021 Update

  • 25 June 2022
Read More

List prices for Medicare negotiation-eligible medicines targeted by Build Back Better drug pricing provisions estimated to be reduced by over 40% on average.

  • 8 June 2022
Read More

Forecasting Drug Price for Reimbursement By Utilizing a Value-Price Relationship, a Case Study in Hormone-Relapsed Prostate Cancer

  • 8 June 2022
Read More

The impact of Value-Based Pricing (VBP) vs International Reference Pricing (IRP) on innovative drugs in the US

  • 1 June 2022
Read More

Yearly Archives

Stay Informed

Sign up to receive the latest news and trends
straight into your inbox from GPI